Bufei Yishen Prescription on Patients With Frequent AECOPD in Stable Stage - Trial NCT06326658
Access comprehensive clinical trial information for NCT06326658 through Pure Global AI's free database. This phase not specified trial is sponsored by Henan University of Traditional Chinese Medicine and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 848 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Henan University of Traditional Chinese Medicine
Timeline & Enrollment
N/A
Apr 01, 2024
Oct 31, 2026
Primary Outcome
The number of acute exacerbations
Summary
To evaluate the clinical efficacy and health economic advantages of Lung Replenishing and
 Kidney Enhancing Formula for the treatment of patients with frequent acute exacerbations in
 the stabilized phase.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06326658
Non-Device Trial